These Are the Health Companies at Risk in the ‘Medicare for All’ Debate

Senator Bernie Sanders, an Independent from Vermont, speaks during a press conference introducing the Medicare for All Act of 2019 in Washington, D.C. on April 10, 2019.

Photographer: Anna Moneymaker/Bloomberg
Lock
This article is for subscribers only.

As presidential hopeful Sen. Bernie Sanders (I-Vt.) grabs headlines with his plan for “Medicare for All” and targets doing away with private health insurance, equity analysts have been working overtime to tell investors what companies have the most to lose.

Health insurers and now hospitals have led the sector-wide plunge even as policy analyst like Veda’s Spencer Perlman argue that Medicare for All has a slim shot at becoming law. With the plan moving 10 percent of GDP to public control from private hands, “it is unprecedented in scale and scope – nothing of this magnitude has ever been attempted, let alone succeeded,” Perlman argues.